Artykuły w czasopismach na temat „Hydergine”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Hydergine”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Nussenblatt, RobertB, HowardA Austin, AlanG Palestine, and HarryG Preuss. "HYDERGINE AND CYCLOSPORIN NEPHROTOXICITY." Lancet 327, no. 8491 (1986): 1220–21. http://dx.doi.org/10.1016/s0140-6736(86)91209-2.
Pełny tekst źródłaTAMURA, TAKASHI, TAIICHI SATOH, HISANORI MINAKAMI, and TARO TAMADA. "Effect of Hydergine in Hyperprolactinemia." Journal of Clinical Endocrinology & Metabolism 69, no. 2 (1989): 470–74. http://dx.doi.org/10.1210/jcem-69-2-470.
Pełny tekst źródłaGuida, Charles V. "Review: Hydergine is effective for dementia." ACP Journal Club 122, no. 1 (1995): 17. http://dx.doi.org/10.7326/acpjc-1995-122-1-017.
Pełny tekst źródłaKho, T. L., R. Kengen, K. M. L. Leunissen, J. Teule, and J. P. Van Hooff. "HYDERGINE AND REVERSIBILITY OF CYCLOSPORIN NEPHROTOXICITY." Lancet 328, no. 8503 (1986): 394–95. http://dx.doi.org/10.1016/s0140-6736(86)90077-2.
Pełny tekst źródła&NA;. "Hydergine-LC appears ineffective in Alzheimer's disease." Inpharma Weekly &NA;, no. 751 (1990): 9–10. http://dx.doi.org/10.2165/00128413-199007510-00027.
Pełny tekst źródłaRomero, R., A. Felip, J. M. Llibre, J. Bonet, and A. Caralps. "Co-Dergocrine Mesylate (Hydergine) and Hypertensive Emergencies." Nephron 51, no. 1 (1989): 127–28. http://dx.doi.org/10.1159/000185270.
Pełny tekst źródłaSchneider, L. S., and J. T. Olin. "Overview of Clinical Trials of Hydergine in Dementia." Archives of Neurology 51, no. 8 (1994): 787–98. http://dx.doi.org/10.1001/archneur.1994.00540200063018.
Pełny tekst źródłaKuskowski, Michael A., Gerald Morley, Stephen M. Malone, Maurice W. Dysken, and Amy Okaya. "Hydergine Treatment and Psychophysiological Measures in Primary Degenerative Dementia." Journal of Geriatric Psychiatry and Neurology 3, no. 1 (1990): 41–47. http://dx.doi.org/10.1177/089198879000300109.
Pełny tekst źródłaSobky, A. El, M. El Shazly, A. K. Darwish, T. Davies, K. Griffin, and M. S. Keshavan. "Hydergine effect on prolactin and reaction time in dementia." Biological Psychiatry 21, no. 12 (1986): 1229–30. http://dx.doi.org/10.1016/0006-3223(86)90230-1.
Pełny tekst źródłaLon, S., M. D. Schneider, T. Jason, and A. M. Olin. "Meta-analysis of hydergine clinical trials in primary dementia." Neurobiology of Aging 13 (January 1992): S123. http://dx.doi.org/10.1016/0197-4580(92)90613-3.
Pełny tekst źródłaTAKEHARA, KAZUHIKO. "Clinical usefulness of hydergine tablets for Raynaud phenomenon in scleroderma." Nishi Nihon Hifuka 58, no. 5 (1996): 840–42. http://dx.doi.org/10.2336/nishinihonhifu.58.840.
Pełny tekst źródłaBECHGAARD, POUL, and LEIF PAULSEN. "Dihydrogenated Ergot Alkaloids (Hydergine) in the Treatment of Essential Hypertension." Acta Medica Scandinavica 145, no. 3 (2009): 189–99. http://dx.doi.org/10.1111/j.0954-6820.1953.tb07010.x.
Pełny tekst źródłaRodriguez, D. V., D. F. Peeler, R. R. Smith, T. S. Sanders, and J. B. Beckett. "ATTENUATION OF ISCHEMIA-REPERFUSION INJURY IN GERBIL HIPPOCAMPUS BY HYDERGINE." Southern Medical Journal 84, Supplement (1991): 42. http://dx.doi.org/10.1097/00007611-199109001-00143.
Pełny tekst źródłaDatta, Kapal D., Richard C. Evenson, Patrick J. Gannon, and Earl P. Dick. "Efficacy of oral hydergine (ergoloid mesylates) in alcohol related encephalopathy." Progress in Neuro-Psychopharmacology and Biological Psychiatry 11, no. 1 (1987): 87–90. http://dx.doi.org/10.1016/0278-5846(87)90035-2.
Pełny tekst źródłaThompson, Troy L., Christopher M. Filley, Wayne D. Mitchell, Kathleen M. Culig, Mary LoVerde, and Richard L. Byyny. "Lack of Efficacy of Hydergine in Patients with Alzheimer's Disease." New England Journal of Medicine 323, no. 7 (1990): 445–48. http://dx.doi.org/10.1056/nejm199008163230704.
Pełny tekst źródłaHarirî, N., B. Falakal, and O. Algan. "THE EFFECTS OF HYDERGINE ON THE SYNAPTIC PLASTICITY OF AGED RATS." Clinical Neuropharmacology 15 (1992): 560B. http://dx.doi.org/10.1097/00002826-199202001-01093.
Pełny tekst źródłaQizilbash, Nawab. "The Cochrane Dementia and Cognitive Impairment Group." Reviews in Clinical Gerontology 7, no. 2 (1997): 183–88. http://dx.doi.org/10.1017/s0959259897000208.
Pełny tekst źródłaPÖLDRE, ARVO. "Two-Year Results of Hydergine Therapy in Hypertension and Other Circulatory Disturbances." Acta Medica Scandinavica 155, no. 6 (2009): 437–48. http://dx.doi.org/10.1111/j.0954-6820.1956.tb14392.x.
Pełny tekst źródłaROTHLIN, E., A. CERLETTI, and H. EMMENEGGER. "Experimental Psycho-neurogenic Hypertension and its Treatment with Hydrogenated Ergot Alkaloids (Hydergine)." Acta Medica Scandinavica 154, S312 (2009): 27–35. http://dx.doi.org/10.1111/j.0954-6820.1956.tb16947.x.
Pełny tekst źródłaSunderland, T., K. T. Putnam, R. Martinez та ін. "COGNITIVE EFFECTS OF LONG-TERM DEPRENYL AND HYDERGINE IN ALZHEIMERʼS DISEASE PATIENTS". Clinical Neuropharmacology 15 (1992): 161B. http://dx.doi.org/10.1097/00002826-199202001-00310.
Pełny tekst źródłalmperato, Assunta, Maria Carmen Obinu, Laura Dazzi, et al. "Co-dergocrine (Hydergine) regulates striatal and hippocampal acetylcholine release through D2 receptors." NeuroReport 5, no. 6 (1994): 674–76. http://dx.doi.org/10.1097/00001756-199402000-00003.
Pełny tekst źródłaKitaoku, Yoshiyuki, Takashi Matsunaga, and Hiroyuki Kitamura. "Clinical Study of Ternelin Therapy and Ternelin and Hydergine Therapy for Tinnitus." Practica Oto-Rhino-Laryngologica 88, no. 5 (1995): 645–56. http://dx.doi.org/10.5631/jibirin.88.645.
Pełny tekst źródłaEhrly, A. M., and K. Saeger-Lorenz. "The effect of Hydergine® on the filterability of erythrocytes from hyperosmolar blood." Clinical Hemorheology and Microcirculation 12, no. 2 (1992): 223–28. http://dx.doi.org/10.3233/ch-1992-12207.
Pełny tekst źródłaSINGH, S. K., J. N. M. IJZERMANS, R. L. MARQUET, R. W. F. DE BRUIN, D. L. WESTBROEK, and J. JEEKEL. "EFFECT OF HYDERGINE ON CYCLOSPORINE-INDUCED NEPHROTOXICITY IN A RAT KIDNEY TRANSPLANTATION MODEL." Transplantation 43, no. 4 (1987): 593–94. http://dx.doi.org/10.1097/00007890-198704000-00033.
Pełny tekst źródłaKAPPERT, ARNOLD, CARL-HENRIK SKOGLUND, ANDERS BERGHOLTZ, and GUSTAV NYLIN. "The Effect of Hydergine (CCK) on Reflex Vasoconstriction and Reflex Blood Pressure Stimulation." Acta Medica Scandinavica 141, no. 6 (2009): 440–50. http://dx.doi.org/10.1111/j.0954-6820.1952.tb14234.x.
Pełny tekst źródłaWerneke, Ursula, Trevor Turner, and Stefan Priebe. "Complementary medicines in psychiatry." British Journal of Psychiatry 188, no. 2 (2006): 109–21. http://dx.doi.org/10.1192/bjp.188.2.109.
Pełny tekst źródłaIzumiyama, K., and K. Kogure. "Effect of dihydroergotoxine mesylate (Hydergine®) on delayed neuronal death in the gerbil hippocampus." Acta Neurologica Scandinavica 78, no. 3 (1988): 214–20. http://dx.doi.org/10.1111/j.1600-0404.1988.tb03649.x.
Pełny tekst źródłaHuber, F., S. Köberle, H. Prestele, and R. Spiegel. "Effects of long-term ergoloid mesylates (‘Hydergine’) administration in healthy pensioners: 5-year results." Current Medical Research and Opinion 10, no. 4 (1986): 256–79. http://dx.doi.org/10.1185/03007998609110447.
Pełny tekst źródłaAmenta, Daniela, Fabio Ferrante, Flavio Franch, and Francesco Amenta. "Effects of Long-Term Hydergine® Administration on Lipofuscin Accumulation in Senescent Rat Brain." Gerontology 34, no. 5-6 (1988): 250–56. http://dx.doi.org/10.1159/000212963.
Pełny tekst źródłaSteurer, G., P. Fitscha, K. Ettl, and H. Sinzinger. "Effects of hydergine on platelet deposition on “active” human carotid artery lesions and platelet function." Thrombosis Research 55, no. 5 (1989): 577–89. http://dx.doi.org/10.1016/0049-3848(89)90390-3.
Pełny tekst źródłaBoulat, O., P. Waldmeier, and L. Maitre. "3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: Effects of hydergine� and vincamine." Journal of Neural Transmission 82, no. 3 (1990): 181–95. http://dx.doi.org/10.1007/bf01272761.
Pełny tekst źródłaHariri, N. I., A. Büyüköztürk, L. Kanit, B. Ersöz, and G. Menteş. "The effects of hydergine on the MAO activity of the aged and adult rat brain." European Neuropsychopharmacology 4, no. 3 (1994): 399–400. http://dx.doi.org/10.1016/0924-977x(94)90231-3.
Pełny tekst źródłaBüyüköztürk, As'lihan, Lütfiye Kanıt, Biltan Ersöz, Gülriz Menteş, and Nuran İ. Hariri. "The effects of hydergine on the MAO activity of the aged and adult rat brain." European Neuropsychopharmacology 5, no. 4 (1995): 527–29. http://dx.doi.org/10.1016/0924-977x(95)80014-s.
Pełny tekst źródłaNAGASAWA, HARUO, KYUYA KOGURE, KOICHIRO KAWASHIMA, TATSUO IDO, MASATOSHI ITOH, and JUN HATAZAWA. "Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography." Tohoku Journal of Experimental Medicine 162, no. 3 (1990): 225–33. http://dx.doi.org/10.1620/tjem.162.225.
Pełny tekst źródłaAmmon, Ronald, Rehka Sharma, Steven R. Gambert, and Krishan Lal Gupta. "Hydergine revisited: A statistical analysis of studies showing efficacy in the treatment of cognitively impaired elderly." AGE 18, no. 1 (1995): 5–9. http://dx.doi.org/10.1007/bf02434076.
Pełny tekst źródłaBullock, R. "Review: hydergine leads to greater global improvement and greater improvement on comprehensive rating scales in dementia." Evidence-Based Mental Health 2, no. 1 (1999): 15. http://dx.doi.org/10.1136/ebmh.2.1.15.
Pełny tekst źródłaShoptaw, Steven, Donnie W. Watson, Chris Reiber, et al. "Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)." Addiction 100 (March 2005): 78–90. http://dx.doi.org/10.1111/j.1360-0443.2005.00991.x.
Pełny tekst źródłaOrma, H., and S. Vannas. "OBSERVATIONS ON THE USE OF PH 203 AND HYDERGINE IN SOME CIRCULATORY DISTURBANCES OF THE FUNDUS AND VASCULAR RETINOPATHY." Acta Ophthalmologica 36, no. 4 (2009): 734–49. http://dx.doi.org/10.1111/j.1755-3768.1958.tb02284.x.
Pełny tekst źródłaMeier-Ruge, W. "Effects of prolonged co-dergocrine mesylate (Hydergine®) treatment on local cerebral glucose uptake in aged Fischer 344 rats." Archives of Gerontology and Geriatrics 5, no. 1 (1986): 65–77. http://dx.doi.org/10.1016/0167-4943(86)90009-9.
Pełny tekst źródłaBertoni-Freddari, C., C. Giuli, C. Pieri, et al. "The Effect of Chronic Hydergine Treatment on the Plasticity of Synaptic Junctions in the Dentate Gyms of Aged Rats." Journal of Gerontology 42, no. 5 (1987): 482–86. http://dx.doi.org/10.1093/geronj/42.5.482.
Pełny tekst źródłaRouy, L. M., A. M. Douillon, R. Compan, and Y. Wolmark. "Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: A 6-month double-blind, placebo-controlled trial." Current Medical Research and Opinion 11, no. 6 (1989): 380–89. http://dx.doi.org/10.1185/03007998909110139.
Pełny tekst źródłaSerino, Anthony, Kwai Kan, Kimberly Graves, Christopher Kule, and Adam Anthony. "Age, strain, and semi-chronic hydergine treatment effects on motor activity and neuronal nucleic acid-protein metabolism in male mice." Life Sciences 67, no. 12 (2000): 1489–505. http://dx.doi.org/10.1016/s0024-3205(00)00732-3.
Pełny tekst źródłaHochberg, Ingrid. "MORPHOLOGICAL STUDIES ON THE EFFECT OF HYDERGINE ON THE ANTERIOR HORN CELLS AND THE CELLS OF NUCLEI VII, X, AND XII." Acta Pathologica Microbiologica Scandinavica 32, no. 2 (2009): 300–315. http://dx.doi.org/10.1111/j.1699-0463.1953.tb00255.x.
Pełny tekst źródłaSchoups, A. A., V. K. Saxena, K. Tombeur та W. P. De Potter. "Facilitation of the release of noradrenaline and neuropeptide Y by the α2-adrenoceptor blocking agents idazoxan and hydergine in the dog spleen". Life Sciences 42, № 5 (1988): 517–23. http://dx.doi.org/10.1016/0024-3205(88)90092-6.
Pełny tekst źródłaAmenta, Francesco, Anne-Lise Jaton, and Alberto Ricci. "Effect of long term hydergine treatment on the age-dependent loss of mossy fibers and of granule cells in the rat hippocampus." Archives of Gerontology and Geriatrics 10, no. 3 (1990): 287–96. http://dx.doi.org/10.1016/0167-4943(90)90030-a.
Pełny tekst źródłaSaletu, B., J. Grünberger, P. Anderer, L. Linzmayer, G. Pakesch, and G. Zyhlarz. "Effect-kinetics on brain protection of two codergocrine-mesylate preparations (Aramexe retard® and Hydergine®) by EEG mapping and psychometry under hypoxia." Archives of Gerontology and Geriatrics 18, no. 2 (1994): 81–99. http://dx.doi.org/10.1016/0167-4943(94)00533-8.
Pełny tekst źródłaArrigo, A., R. Casale, I. Giorgi, C. Guarnaschelli, and F. Zelaschi. "Effects of Intravenous High Dose Co-Dergocrine Mesylate (‘Hydergine’®) in Elderly Patients with Severe Multi-Infarct Dementia: a Double-Blind, Placebo-Controlled Trial." Current Medical Research and Opinion 11, no. 8 (1989): 491–500. http://dx.doi.org/10.1185/03007998909110460.
Pełny tekst źródłaUnseld, H. "Vasospasmus nach Leberruptur, Dopamin- und Hydergin®-Infusion." AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie 20, no. 06 (1985): 339–41. http://dx.doi.org/10.1055/s-2007-1003135.
Pełny tekst źródłaGripwall, E., and A. Pöldre. "Einige Erfahrungen aus der Behandlung von essentieller Hypertonie mit Hydergin." Acta Medica Scandinavica 154, S312 (2009): 245–47. http://dx.doi.org/10.1111/j.0954-6820.1956.tb16991.x.
Pełny tekst źródłaThienhaus, Ole J., Beverly G. Wheeler, Sandra Simon, Frank P. Zemlan, and James T. Hartford. "A Controlled Double-Blind Study of High-Dose Dihydroergotoxine Mesylate (HydergineR) in Mild Dementia." Journal of the American Geriatrics Society 35, no. 3 (1987): 219–23. http://dx.doi.org/10.1111/j.1532-5415.1987.tb02312.x.
Pełny tekst źródła